Literature DB >> 4074494

Catabolic pathways for high-dosed L(-)- or D(+)-carnitine in germ-free rats?

H Seim, J Schulze, E Strack.   

Abstract

Gnotobiotic rats received up to 3 mmol L-carnitine/day with the drinking water during 9 days. They excreted about a quarter of the administered dose with the urine, partially in form of acetyl-L-carnitine, but trimethylamine, trimethylamine N-oxide or gamma-butyrobetaine were not detectable in urine or faeces in contrast to conventional animals. After oral loading with D-carnitine the unphysiological isomer was absorbed and either excreted unchanged in urine or metabolized to acetonyltrimethylammonium. With regard to the development of carnitine deficiency syndromes and the degradation of nutritional carnitine the conclusion has to be drawn, that the bacteria of the gastro-intestinal tract, but not the tissues of the mammals, are responsible for the metabolization of L-carnitine to gamma-butyrobetaine or trimethylamine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074494     DOI: 10.1515/bchm3.1985.366.2.1017

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  7 in total

1.  γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.

Authors:  Robert A Koeth; Bruce S Levison; Miranda K Culley; Jennifer A Buffa; Zeneng Wang; Jill C Gregory; Elin Org; Yuping Wu; Lin Li; Jonathan D Smith; W H Wilson Tang; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

2.  Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.

Authors:  P Harper; C E Elwin; G Cederblad
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.

Authors:  P Harper; C E Elwin; G Cederblad
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota.

Authors:  Lesley Hoyles; Maria L Jiménez-Pranteda; Julien Chilloux; Francois Brial; Antonis Myridakis; Thomas Aranias; Christophe Magnan; Glenn R Gibson; Jeremy D Sanderson; Jeremy K Nicholson; Dominique Gauguier; Anne L McCartney; Marc-Emmanuel Dumas
Journal:  Microbiome       Date:  2018-04-20       Impact factor: 14.650

5.  A highly sensitive liquid chromatography electrospray ionization mass spectrometry method for quantification of TMA, TMAO and creatinine in mouse urine.

Authors:  Sunil Veeravalli; Kersti Karu; Ian R Phillips; Elizabeth A Shephard
Journal:  MethodsX       Date:  2017-09-28

6.  Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved?

Authors:  Carolina Baraldi A Restini; Gregory D Fink; Stephanie W Watts
Journal:  Pharmacol Res       Date:  2020-11-13       Impact factor: 7.658

Review 7.  Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease.

Authors:  Diede Fennema; Ian R Phillips; Elizabeth A Shephard
Journal:  Drug Metab Dispos       Date:  2016-05-17       Impact factor: 3.922

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.